Novel Mixture of Pozelimab and Cemdisiran (Poze-Cemdi) Achieved Better Management of Intravascular Hemolysis in Sufferers with Paroxysmal Nocturnal Hemoglobinuria In comparison with Ravulizumab
Head-to-head exploratory cohort of a Section 3 trial confirmed first-in-class poze-cemdi mixture…
